Man Group plc Makes New Investment in Acadia Healthcare Company, Inc. $ACHC

Man Group plc acquired a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the 2nd quarter, HoldingsChannel.com reports. The firm acquired 255,147 shares of the company’s stock, valued at approximately $7,534,000.

Several other institutional investors also recently bought and sold shares of ACHC. Clough Capital Partners L P bought a new stake in shares of Acadia Healthcare in the first quarter worth about $5,359,000. Deutsche Bank AG purchased a new position in Acadia Healthcare during the 2nd quarter valued at approximately $49,746,000. Lisanti Capital Growth LLC bought a new stake in Acadia Healthcare in the 2nd quarter worth approximately $4,502,000. Bank of America Corp DE raised its holdings in shares of Acadia Healthcare by 64.7% during the 1st quarter. Bank of America Corp DE now owns 1,231,172 shares of the company’s stock worth $28,797,000 after acquiring an additional 483,649 shares in the last quarter. Finally, Royal Bank of Canada grew its holdings in shares of Acadia Healthcare by 7,896.1% in the first quarter. Royal Bank of Canada now owns 278,265 shares of the company’s stock valued at $6,508,000 after purchasing an additional 274,785 shares in the last quarter.

Acadia Healthcare Trading Down 5.5%

Shares of ACHC opened at $28.55 on Friday. The company’s fifty day simple moving average is $30.46 and its 200-day simple moving average is $26.06. The company has a market cap of $2.66 billion, a P/E ratio of -2.29, a P/E/G ratio of 9.20 and a beta of 0.64. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The firm had revenue of $865.84 million during the quarter, compared to analysts’ expectations of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The firm’s revenue for the quarter was down .4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ACHC. KeyCorp upped their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada lifted their price objective on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price objective on the stock in a research note on Monday, May 4th. Finally, Barclays raised their price objective on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $29.85.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.